Cite
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
MLA
Boilève, Alice, et al. “Molecular Profiling and Target Actionability for Precision Medicine in Neuroendocrine Neoplasms: Real-World Data.” European Journal of Cancer, vol. 186, June 2023, pp. 122–32. EBSCOhost, https://doi.org/10.1016/j.ejca.2023.03.024.
APA
Boilève, A., Faron, M., Fodil-Cherif, S., Bayle, A., Lamartina, L., Planchard, D., Tselikas, L., Kanaan, C., Scoazec, J. Y., Ducreux, M., Italiano, A., Baudin, E., & Hadoux, J. (2023). Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. European Journal of Cancer, 186, 122–132. https://doi.org/10.1016/j.ejca.2023.03.024
Chicago
Boilève, Alice, Matthieu Faron, Sarah Fodil-Cherif, Arnaud Bayle, Livia Lamartina, David Planchard, Lambros Tselikas, et al. 2023. “Molecular Profiling and Target Actionability for Precision Medicine in Neuroendocrine Neoplasms: Real-World Data.” European Journal of Cancer 186 (June): 122–32. doi:10.1016/j.ejca.2023.03.024.